All data are based on the daily closing price as of November 11, 2026
s

Sawai Group Holdings

4887.TSE
10.56 USD
-0.13
-1.22%

Overview

Last close
10.56 usd
Market cap
1.22B usd
52 week high
15.73 usd
52 week low
9.89 usd
Target price
13.95 usd

Valuation

P/E
20.3715
Forward P/E
16.7785
Price/Sales
0.9509
Price/Book Value
1.0986
Enterprise Value
1.81B usd
EV/Revenue
1.4118
EV/EBITDA
9.4559

Key financials

Revenue TTM
1.28B usd
Gross Profit TTM
367.80M usd
EBITDA TTM
216.43M usd
Earnings per Share
0.52 usd
Dividend
0.35 usd
Total assets
2.85B usd
Net debt
717.54M usd

About

Sawai Group Holdings Co., Ltd., together with subsidiaries, engages in the manufacture and sale of pharmaceuticals. The company offers generic drugs in various dosage forms for therapeutic areas comprising cardiovascular and antibiotic preparations, central nervous system drugs, other metabolic drugs, digestive tract medicines, blood and body fluid medications, allergy medications, respiratory medicine, vitamin supplements, oncology drugs, chemotherapeutic agents, genitourinary and anal drugs, and others. It sells its generic drugs through distributors, wholesalers, and retailers. Sawai Group Holdings Co., Ltd. was founded in 1929 and is headquartered in Osaka, Japan.
  • Symbol
    4887.TSE
  • Exchange
    TSE
  • Isin
    JP3323040000
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Mitsuo Sawai
  • Headquarter
    Osaka
  • Web site
    https://www.sawaigroup.holdings
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top